Clinical Cell Culture renames
Tuesday, 10 June, 2008
Clinical Cell Culture (ASX: CCE) is to be re-named Avita Medical following a shareholder meeting.
The resolution to change the company's name was passed by the vast majority of shareholders.
Shareholders have also resolved to consolidate the company's shares on a 10:1 basis.
The company believes that a name change and the recent shake-up of the boardroom will help drive sales of the company's products, such as the ReCell autologous skin cell kit, further.
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
